Treatment Transitions: Exploring Clinical Responses to Ruxolitinib Monotherapy for Atopic Dermatitis Management

Video content above is prompted by the following question(s):

• How do the study findings align with your own clinical experiences and observations in managing patients with atopic dermatitis (AD)?
• What additional information would you find valuable to assess the real-world effectiveness of ruxolitinib cream in managing AD, beyond what was presented in the study methodology?
• Please comment on how physician satisfaction has influenced the adoption and integration of ruxolitinib cream in clinical practice.